Anti-CD19 CAR-T cell therapy for acquired hemophilia A

被引：0
|
作者：
Schultze-Florey, Christian R. [1 ]
Thol, Felicitas R. [1 ]
Aleksandrova, Krasimira [2 ]
Stoyanov, Kalin [1 ]
Gutierrez Jauregui, Rodrigo [3 ]
Arseniev, Lubomir [2 ]
Leise, Jana [2 ]
Kloess, Stephan [2 ]
Heidel, Florian H. [1 ,2 ,4 ]
Tiede, Andreas [1 ]
机构：
[1] Hannover Med Sch, Hematol Hemostasis Oncol & Stem Cell Transplantat, Hannover, Germany
[2] Hannover Med Sch, Cellular Therapy Ctr, Hannover, Germany
[3] Hannover Med Sch, Inst Immunol, Hannover, Germany
[4] Leibniz Inst Aging, Fritz Lipmann Inst, Jena, Germany
来源：
LEUKEMIA | 2025年
关键词：
D O I：
10.1038/s41375-025-02554-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：980 / 982
页数：3
相关论文
共 50 条
  • [21] Perforin Is Dispensable for Anti-CD19 CAR-T Cell Cytotoxicity but Contributes to CAR-T Cell Contraction and Regulates Host Inflammatory Response
    Ishii, Kazusa
    Chien, Christopher Daniel
    Erwin-Cohen, Rebecca
    Young, Howard A.
    Fry, Terry J.
    BLOOD, 2017, 130
  • [22] Effect of CD22-directed CAR-T cells secreting anti-CD19 T cell engagers on control of leukemia progression compared to tandem anti-CD19/CD22 CAR-T cells.
    Arroyo-Rodenas, Javier
    Diez-Alonso, Laura
    Falgas, Aida
    Martinez-Moreno, Alba
    Gil-Etayo, Francisco Javier
    Aguilar-Sopena, Oscar
    Velasco-Sidro, Miriam
    Bravo-Martin, Clara
    Ramirez-Fernandez, Angel
    Jimenez-Reinoso, Anais
    Blanco, Belen
    Roda-Navarro, Pedro
    Bueno, Clara
    Menendez, Pablo
    Alvarez-Vallina, Luis
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [23] Universal Pharmacokinetic Assessment of Anti-CD19 CAR-T Using Biocytometry
    Cienciala, Martin
    Kasl, Hynek
    Fikar, Pavel
    Berne, Laura
    Holubova, Monika
    Lysak, Daniel
    Georgiev, Daniel
    MOLECULAR THERAPY, 2024, 32 (04) : 872 - 873
  • [24] Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
    Mackensen, Andreas
    Mueller, Fabian
    Mougiakakos, Dimitrios
    Boeltz, Sebastian
    Wilhelm, Artur
    Aigner, Michael
    Voelkl, Simon
    Simon, David
    Kleyer, Arnd
    Munoz, Luis
    Kretschmann, Sascha
    Kharboutli, Soraya
    Gary, Regina
    Reimann, Hannah
    Roesler, Wolf
    Uderhardt, Stefan
    Bang, Holger
    Herrmann, Martin
    Ekici, Arif Buelent
    Buettner, Christian
    Habenicht, Katharina Maria
    Winkler, Thomas H.
    Kroenke, Gerhard
    Schett, Georg
    NATURE MEDICINE, 2022, 28 (10) : 2124 - 2132
  • [25] Anti-CD19 antibody cotreatment enhances serial killing activity of anti-CD19 CAR-T/-NK cells and reduces trogocytosis
    Koh, Seung Kwon
    Kim, Hyojin
    Han, Bohwa
    Jo, Hantae
    Doh, Junsang
    Park, Jeehun
    Ha Nguyen, Minh
    Kim, Hyun-Young
    Kim, Haneul
    Lee, Seung-Hwan
    Kim, Chan Hyuk
    Cho, Duck
    BLOOD, 2025, 145 (09) : 956 - 969
  • [26] HUMAN BINDING DOMAINS REDUCE NEUROTOXICITY OF ANTI-CD19 CAR-T CELLS
    不详
    CANCER DISCOVERY, 2020, 10 (03) : 338 - 338
  • [27] Thrombopoietin receptor agonists for acquired thrombocytopenia following anti-CD19 CAR-T-cell therapy: a case report
    Baur, Rebecca
    Jitschin, Regina
    Kharboutli, Soraya
    Stoll, Andrej
    Voelkl, Simon
    Buettner-Herold, Maike
    Schmidt, Daniela
    Roesler, Wolf
    Mackensen, Andreas
    Mougiakakos, Dimitrios
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (07)
  • [28] Pembrolizumab for the treatment of progressive multifocal leukoencephalopathy following anti-CD19 CAR-T therapy: a case report
    Mackenzie, Strachan
    Shafat, Manar
    Roddy, Harriet
    Hyare, Harpreet
    Neill, Lorna
    Marzolini, Maria A. V.
    Gilhooley, Michael
    Marafioti, Teresa
    Kara, Eleanna
    Sanchez, Emilie
    Rees, Jeremy
    Lynch, David S.
    Thomson, Kirsty
    Ardeshna, Kirit M.
    Laurence, Arian
    Peggs, Karl S.
    O'Reilly, Maeve
    Roddie, Claire
    EJHAEM, 2021, 2 (04): : 848 - 853
  • [29] Anti-CD19/CD22 Dual CAR-T Therapy for Refractory and Relapsed B-Cell Acute Lymphoblastic Leukemia
    Yang, Junfang
    Jiang, Pengfei
    Zhang, Xian
    Zhu, Xiaobin
    Dong, Qi
    He, Jiaping
    Lin, Nanjing
    Wang, Zhenguang
    Cai, Songbai
    Ye, Xun
    Su, Yunchao
    Li, Wenqian
    Li, Jingjing
    Yu, Ziyao
    He, Jiujiang
    Xu, Li
    Song, Dan
    Cao, Wei
    Lu, Peihua
    BLOOD, 2019, 134
  • [30] Anti-CD19 CAR T-cell therapy remission despite prior anti-CD19 antibody Tafasitamab in relapsed/refractory DLBCL
    Tabbara, Nadeem
    Gaut, Daria
    Oliai, Caspian
    Lewis, Tara
    de Vos, Sven
    LEUKEMIA RESEARCH REPORTS, 2021, 16
12345